ID   S-9-11
AC   CVCL_XA77
DR   CCRID; 4201PAT-CCTCC00168
DR   Wikidata; Q98129249
RX   Patent=CN100519583C;
RX   PubMed=18986662;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200515.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P59594; Human SARS coronavirus (SARS-CoV) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 7
//
RX   Patent=CN100519583C;
RA   Sun B., Bian C., Zhang L.-Q.;
RT   "SARS neutralization antibody and application.";
RL   Patent number CN100519583C, 29-Jul-2009.
//
RX   PubMed=18986662; DOI=10.1016/j.virol.2008.09.029;
RA   Bian C., Zhang X.-Q., Cai X.-F., Zhang L.-Q., Chen Z.-W., Zha Y.,
RA   Xu Y., Xu K., Lu W., Yan L.-C., Yuan J.-W., Feng J.-N., Hao P.,
RA   Wang Q.-D., Zhao G.-P., Liu G., Zhu X.-L., Shen H., Zheng B.-J.,
RA   Shen B.-F., Sun B.;
RT   "Conserved amino acids W423 and N424 in receptor-binding domain of
RT   SARS-CoV are potential targets for therapeutic monoclonal antibody.";
RL   Virology 383:39-46(2009).
//